TecDAX

A wave of skepticism is beginning to temper the prolonged enthusiasm for artificial intelligence that has buoyed the technology sector....

The fate of CureVac's independent stock market journey has been sealed. BioNTech has successfully cleared the final hurdle for its...

CureVac is undergoing a decisive transformation, shifting from an independent mRNA pioneer to a fully integrated unit within BioNTech. With...

For investors in BioNTech, the company's long-stated pivot beyond its COVID-19 vaccine foundation has awaited concrete validation. This week, the...

All eyes are on Synopsys this week as the company prepares to release its quarterly results. The upcoming financial report,...

The solar technology firm Enphase Energy is advancing its product portfolio with significant launches in the U.S. and European markets....

A wave of aggressive price target upgrades is sweeping through analyst coverage of Lumentum Holdings Inc. today. This bullish sentiment...

Following an impressive year-long rally, shares of Advanced Energy Industries now face a critical test. While market experts maintain a...

A steep decline in the share price of Advanced Micro Devices (AMD) has unsettled many investors, fueling widespread debate. However,...

A significant deadline has arrived for one of Germany's most closely watched biotech narratives. The offer period for BioNTech's exchange...